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asthma and allergies. The aim of the present work is to pro-
vide the stepwise proceedings of the development and cur-
rent version of the harmonized MeDALL-Core Question-
naire (MeDALL-CQ) used prospectively in 11 European birth 
cohorts.  Methods: The harmonization of questions was ac-
complished in 4 steps: (i) collection of variables from 14 
birth cohorts, (ii) consensus on questionnaire items, (iii) 
translation and back-translation of the harmonized English 
MeDALL-CQ into 8 other languages and (iv) implementa-
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 Abstract 
 Background: Numerous birth cohorts have been initiated 
in the world over the past 30 years using heterogeneous 
methods to assess the incidence, course and risk factors of 
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tion of the harmonized follow-up.  Results: Three harmo-
nized MeDALL-CQs (2 for parents of children aged 4–9 and 
14–18, 1 for adolescents aged 14–18) were developed and 
used for a harmonized follow-up assessment of 11  European 
birth cohorts on asthma and allergies with over 13,000 chil-
dren.  Conclusions: The harmonized MeDALL follow-up pro-
duced more comparable data across different cohorts and 
countries in Europe and will offer the possibility to verify 
results of former cohort analyses. Thus, MeDALL can be-
come the starting point to stringently plan, conduct and 
support future common asthma and allergy research initia-
tives in Europe.  © 2014 S. Karger AG, Basel 
 Introduction 
 Numerous cohorts focusing on asthma and allergy 
have been initiated in the world over the past 30 years, 
most of them focusing on the evaluation of incidence, 
course and risk factors of asthma and allergies  [1, 2] . In 
Europe, the costs of persistent asthma were estimated at 
EUR 19.3 billion and most costs were due to young pa-
tients aged 15–30 years  [3] . The questionnaires used by 
many cohorts to assess symptoms of asthma and rhini-
tis included several questions based on those developed 
and validated in the worldwide International Study of 
Asthma and Allergies in Childhood (ISAAC)  [4] . Al-
though the order and/or wording of the ISAAC ques-
tions were usually slightly modified, questions on asth-
ma and allergic rhinitis were homogeneously assessed 
across European birth cohorts. On the other hand, the 
assessment of other allergic phenotypes (e.g. eczema, 
sensitization to aero- and food allergens), pulmonary 
development and possible determinants of allergic dis-
eases, including dietary habits and environmental expo-
sures, were rather heterogeneous  [1, 2] . MeDALL at-
tempts to increase the amount of harmonized questions 
beyond those included in the ISAAC questionnaire or 
those which might have been included in the ISAAC 
questionnaire but were not frequently used by the co-
horts in the last years.
 Since 2004, several research initiatives funded under 
the EU Framework Program for Research and Techno-
logical Development FP6-FP7 have attempted to iden-
tify, compare and evaluate pooled data from existing 
 European birth cohorts  [5] : GA 2 LEN (Global Allergy 
and European Network,  FP6)  [6] , ENRIECO (Environ-
mental Health Risks in European Birth Cohorts, FP7) 
 [7] , CHICOS (Developing a Child Cohort Research 
Strategy for Europe, FP7) and MeDALL (Mechanisms of 
the Development of Allergy, FP7)  [8–10] . Combined 
analyses across birth cohorts result in larger sample 
 sizes  and increased statistical power, and broaden the 
diversity of environmental exposure assessments and 
 facilitate research on underlying mechanisms explain-
ing heterogeneous results among the cohorts  [11] .
 Combining birth cohort data can be done retrospec-
tively on historical data or prospectively by using the 
same core questionnaire and standard operating proce-
dures for physical examinations. The collaborative 
MeDALL project aims to integrate epidemiological and 
clinical research and to identify inherited and environ-
mental factors associated with the onset of allergy in chil-
dren  [8, 9] . Within this project, combined analyses of his-
torical data from 14 European birth cohorts are under-
way. Moreover, MeDALL harmonizes a core assessment 
for follow-up of 11 birth cohorts in order to prospective-
ly collect data on asthma and allergies. It is of importance 
that historical and prospective questions are interopera-
ble to compare data.
 Questionnaires for birth cohorts are collected accord-
ing to the age at examination. In adolescents question-
naires are completed by the participants and their par-
ents, whereas in school children (under 10 years) ques-
tionnaires are given to the parents only. In MeDALL, 
participants of 8 birth cohorts are older than 13 years (in 
the following referred to as the ‘older birth cohorts’) and 
participants of 6 others are younger than 10 years (in the 
following referred to as the ‘younger birth cohorts’) at the 
time of the harmonized follow-up.
 The aim of the present work is to provide the stepwise 
proceedings of the development and current version of 
the MeDALL-Core Questionnaire (MeDALL-CQ) used 
prospectively in over 13,000 children. More specifically: 
(1) different working steps and the item selection process 
for the harmonized MeDALL-CQ are described and (2) 
the 3 English MeDALL-CQs, namely the parental 
(MeDALL-PQ, 14–18 years) and adolescent (MeDALL-
AQ, 14–18 years) versions for the older birth cohorts and 
the parental questionnaire (MeDALL-PQ, 4–9 years) for 
the younger birth cohorts are presented in the online sup-
plementary material (for all online suppl. material, see 
www.karger.com/doi/10.1159/000357732). (3) Transla-
tions in 8 languages and standard operating procedures 
for clinical examinations are available but not included in 
the present paper. They can be retrieved by contacting the 
corresponding author. The harmonized MeDALL fol-
low-up is ongoing and resulting data will be presented in 
following publications.
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 Materials and Methods 
 Members of MeDALL-CQ 
 Members of 8 older European MeDALL birth cohorts (AMICS-
Menorca, BAMSE, DARC, ECA, GINIplus, LISAplus, MAS and 
PIAMA-NHS) developed and approved a common harmonized 
MeDALL-CQ for adolescent participants (MeDALL-AQ, 14–
18 years) and their parents (MeDALL-PQ, 14–18 years;  table 1 ).
 Members of 6 younger European MeDALL birth cohorts (BiB, 
EDEN, INMA, PARIS, ROBBIC and RHEA) developed and ap-
proved a common harmonized MeDALL-PQ, for children aged 
4–9 years ( table 2 ).
 Development of MeDALL-CQ 
 The harmonization of questions was conducted for 8 major 
sections ( table 3 ) in 4 steps: (i) collection of variables from 14 birth 
cohorts, (ii) consensus on questionnaire items, (iii) translation and 
back-translation of the harmonized English MeDALL-CQ in 8 
other languages and (iv) implementation of the harmonized fol-
low-up ( fig. 1 ).
 During the process, it was important to reach a consensus on 
the inclusion of the questionnaire items by achieving a maximal 
harmonization between the cohorts and, at the same time, not to 
endanger longitudinal comparisons within each cohort. The 
MeDALL-CQ included core questions but also shared additional 
questions and gave the cohorts the opportunity to include a num-
ber of their own individual questions. This questionnaire, available 
in 9 different languages, was used prospectively by 11 MeDALL 
birth cohorts.
 Sections and Item Selection for the MeDALL-CQ 
 Health Outcomes 
 The definitions for asthma, rhinitis and eczema were based on 
a MeDALL consensus meeting held in Barcelona, June 2011  [12] .
Table 1.  The eight birth cohorts (participant age 14–18 years) that took part in the development of a harmonized MeDALL-CQ
Birth cohort Country/region Year of 
recruitment
Size at 
recruitment, 
n
Age at MeDALL
follow-up, years
Size at MeDALL 
follow-up 
(expected), n  
BAMSE Sweden/Stockholm 1994–1996 4,089 16–18 3,300
PIAMA-NHS The Netherlands/North, West and Central 1996–1997 3,963 15–17 2,500
GINIplus Germany/Munich, Wesel 1996–1998 5,991 14–17 2,050
LISAplus Germany/Munich, Wesel, Leipzig, Bad Honnef 1997–1998 3,097 15–17 1,050
AMICS-Menorca Spain/Menorca 1997–1998 485 14–15 380
DARC Denmark/Odense 1998–1999 562 14–15 450
ECA Norway/Oslo 1992–1993 3,754 16–17 550
MAS Germany/Berlin, Düsseldorf, Mainz, Freiburg,
Munich
1990 1,314 20 790
 Six of the cohorts took part in the common MeDALL follow-up assessment and two birth cohorts (ECA, MAS) had a follow-up based 
on own funding.
Table 2.  The six birth cohorts (participant age 4–9 years) that took part in the development of a harmonized MeDALL-CQ and the com-
mon MeDALL follow-up assessment
Birth cohort Country/region Year of
recruitment
Size at
recruitment, 
n
Age at MeDALL
follow-up, years
Size at MeDALL 
follow-up 
(expected), n
BiB UK/Bradford 2007–2010 13,776 4 1,500
INMA Spain/Valencia, Sabadell, Guipuzkoa 2004–2008 3,768 4–7 1,100
PARIS France/Paris 2003–2006 4,115 8 900
RHEA Greece/Heraklion, Crete 2007–2008 1,497 4 900
ROBBIC Italy/Rome,
Italy/Bologna
2003
2003
709
654
8–9 700
EDEN France/Nancy, Poitiers 2003–2006 1,896 5 900
 Five of the cohorts took part in the common MeDALL follow-up assessment and one birth cohort (EDEN) had a follow-up based on 
own funding, which did not use the MeDALL-CQ.
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 Asthma. ISAAC questions on wheezing symptoms  [4] , ques-
tions on doctor’s diagnosis, hospital visits and medication intake 
were chosen to assess the prevalence and severity of asthma. Based 
on the decisions of the working group the adolescent core ques-
tionnaire, AQ, contained additional questions on tightness of chest 
and shortness of breath since these symptoms are also considered 
as ‘key indicators for considering a diagnosis of asthma’  [13] . The 
triad of respiratory symptoms (wheezing and/or tightness of chest 
and/or shortness of breath), doctor’s diagnosis and medication in-
take was used for a questionnaire-based definition of asthma in 
children and adolescents  [8, 14, 15] . In the MeDALL-AQ, a visual 
analog scale was used to estimate asthma and its impact on daily 
life, as these scales are more sensitive to small outcome differences 
than, for example, ordinal scales are  [16] , and may be relevant to 
assess the control of asthma  [8] . Depending on country-specific 
differences, the wording of the question regarding an asthma di-
agnosis by a doctor might be adapted (e.g. additional questions for 
doctor’s diagnosis of obstructive, asthmatic or spastic bronchitis 
for German-speaking countries). Questions for which it was un-
clear whether the judgment about the illness was based on a doc-
tor’s diagnosis or on self-diagnosis were not incorporated. More-
over, the MeDALL-CQs gave the cohorts the opportunity to in-
clude a number of cohort-specific questions to allow for 
consistency with earlier follow-ups. For the asthma section, this 
comprises questions on seasonal variations of symptoms, chronic 
obstructive lung disease and further details of medication intake. 
These questions were included in the section for optional use.
 Rhinitis. The presence of rhinitis can be assessed by question-
naire assessment, while allergic rhinitis can be assessed by a ques-
tionnaire on nasal symptoms and the demonstration of an IgE-
mediated sensitization to specific allergens (using skin-prick test-
ing and/or specific serum IgE assays) only. Seasonal and 
perennial rhinitis were distinguished by the inclusion of ISAAC 
questions on current (last 12 months) and seasonal rhinitis symp-
toms  [4] . In addition, questions about medication use and prior 
allergen-specific immunotherapy were included. If only current 
symptoms are assessed, children with medication intake might 
wrongly be categorized as healthy because the extent of their cur-
rently experienced symptoms might be profoundly reduced by 
the treatment received. Questions based on ARIA were used to 
assess the duration and severity of allergic rhinitis  [17] . In the 
MeDALL-AQ, 14–18 years, questions on rhinosinusitis were in-
cluded based on suggestions in the European Position Paper on 
Rhinosinusitis and Nasal Polyps (EP 3 OS) emphasizing the impor-
tance of the current lack of knowledge about the incidence and 
prevalence of rhinosinusitis in European countries, and the need 
for ‘large-scale epidemiologic research’  [18, 19] .  
Eczema.  The diagnosis of eczema by a doctor and the preva-
lence, severity and seasonal variations of eczema symptoms were 
assessed by means of items from the ISAAC questionnaire  [4] and 
the Williams’ and UK working criteria  [20] . Moreover, questions 
on contact dermatitis were included. Concerning eczema severity, 
the POEM (Patient-Oriented Eczema Measure)  [21] was part of 
the supplemental questionnaire which assesses self-reported re-
cent eczema severity over the last 7 days. As for wheezing and 
 rhinitis symptoms in epidemiological studies, the corresponding 
POEM-based eczema severity questions referred to the last 12 
months. This method of assessing self-reported eczema severity 
will be validated by two of the birth cohorts during the course of 
MeDALL (BAMSE and DARC).
 Possible Determinants of Allergic Diseases 
 Parental Allergies. Family history is a relevant risk factor of al-
lergic diseases and regular assessments of parental allergies are 
necessary to record different patterns which might influence chil-
dren’s allergies  [22] . Thus, the MeDALL-PQ contains questions on 
the diagnosis of asthma, rhinitis and eczema of both parents, also 
including age at onset of the disease and the differentiation be-
tween the doctor’s diagnosis and self-diagnosis. Although infor-
mation on parental allergies was already collected in former ques-
tionnaires (for most cohorts at birth) the differentiation between 
a self-diagnosis versus a doctor’s diagnosis was lacking in most 
cohorts.
 Nutrition. The birth cohorts participating in MeDALL are geo-
graphically spread across the European continent from Norway 
Table 3.  Major sections of the common MeDALL questionnaire
1. Asthma
2. Allergic rhinitis
3. Eczema
4. Socio-demographic questions
5. Nutrition
6. Indoor environment (dampness/mold, tobacco smoke 
 exposure, air pollution)
7. Lifestyle factors (physical activity, smoking, alcohol and drugs)
8. Puberty development
Step I
month 1
Step II
months 
2–8
Step III
months 
9–12
Step IV
months
13–32
 Implementation of MeDALL-CQ in the individual 
 follow-up of the cohorts
 3 face-to-face meetings to discuss inclusion and
 exclusion of questionnaire items
 Consensus for English MeDALL-CQ is established 
 between all partners
 English translation of 13 cohort questionnaires of
 last follow-up
 Review of questionnaire items
 First evaluation of differences and similarities of
 cohort questionnaires
 Translation of English questionnaires into Dutch,
 Danish, French, Italian, Spanish, Swedish, German
 and Greek
 English back-translation checked for inconsistencies
 compared to original English questionnaire
 Fig. 1. Overview of the different working steps of the development 
of the harmonized MeDALL-Core Questionnaires (CQ) currently 
used by 11 European birth cohorts. 
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and Sweden in the north to Spain and Greece in the south, covering 
various climatic and cultural regions with heterogeneous nutri-
tional habits  [23, 24] . Due to these considerable differences in diet 
among the MeDALL birth cohort study participants, and also re-
flected by the different instruments used in previous nutritional 
assessments in each of the cohorts, harmonized food questions 
could not be identified. However, all MeDALL cohorts assessed 
data on the food-item level by using cohort-specific food frequen-
cy questionnaires. Common questions for the MeDALL-CQs were 
agreed upon by the MeDALL partners to assess self- and parent-
reported allergic reactions to food, including the age at first reac-
tion, the type of allergic reaction and current allergic reactions to 
food items.
 Indoor Environment. ‘Cooking with gas’ was included in the 
MeDALL-PQ and the inclusion of variables such as kitchen venti-
lation or the ‘presence of other sources of combustion products’ 
were not expected to explain additional variance when investigat-
ing respiratory health outcomes  [25] . Three questions on ‘damp-
ness and/or mold within the home’ were adapted from the LISA-
plus and GINIplus cohorts aiming to follow-up a previous meta-
analysis that suggested a possible link with wheezing and allergic 
rhinitis  [15] . The parents were considered to be a more reliable 
source of information concerning the indoor environment at 
home than the adolescents. Active and passive tobacco smoke ex-
posure, however, needed to be included in both the parental 
MeDALL-PQ as well as the adolescent MeDALL-AQ, since par-
ents are not likely to know (exactly) their teenaged children’s to-
bacco exposure outside the home.
 Lifestyle Factors. In the MeDALL-AQ, 14–18 years, questions 
on physical activity, smoking, alcohol and drug consumption were 
included. For this purpose, the International Physical Activity 
Questionnaire (IPAQ)  [26] was adapted to the needs of an epide-
miological study. Instead of asking for physical activity during the 
last 7 days, which could be useful in cross-sectional or short-term 
intervention studies, the corresponding IPAQ-based MeDALL 
questions asked for physical activity during a typical week in the 
last 12 months in summer and, separately, in winter. It is planned 
to validate this assessment in the German LISA birth cohort by us-
ing accelerometers. Besides active smoking, questions on passive 
smoking at indoor locations were added to the MeDALL-PQ, dis-
tinguishing between second-hand smoke exposures ‘at home’ and 
‘not at home’. Alcohol and drug consumption were assessed each 
by two questions asking for the type of alcohol/drug and the 
amount of intake as glasses per week or times of intake in the last 
12 months, adapted from the KiGGS survey  [27] . The unit ‘num-
ber of sips’ used before by some of the cohorts was not considered 
as a valid proxy for current drinking behavior in adolescents. No 
consensus was reached about questions on binge drinking, but the 
following 2 questions were recommended for optional use: ‘have 
you ever drunk that much alcohol that you have been dizzy or sick 
afterwards? If yes, how often in the last 12 months?’ and ‘have you 
ever drunk that much alcohol that you could not remember every-
thing from the day before?’, which have been used in former ques-
tionnaires by the cohorts GINIplus and LISAplus.
 Puberty Development. In the MeDALL-ACQ, puberty develop-
ment was assessed by the Pubertal Development Scale (PDS)  [28] . 
The prospectively collected data since birth in the MeDALL co-
horts provides the unique possibility to investigate determinants 
of the postulated sex-switch in the prevalence of asthma and aller-
gic diseases during puberty  [29] .
 Other Questions. The MeDALL-AQ contained questions on 
height, weight and school degree/level of schooling of the adoles-
cent participants. Although allergies might play a minor role in 
adolescents’ job choices  [30] , items inquiring whether the choice 
of schooling programs is affected by allergic diseases were includ-
ed so that the prevalence of current allergic symptoms would not 
be underestimated due to the avoidance of known allergens. Fur-
thermore, this question could give an idea of the severity of the 
allergic disease and its impact on the choices of the adolescent re-
garding everyday life. The items of this section were extracted from 
former cohort questionnaires and agreed on by all MeDALL birth 
cohorts.
 Results 
 The three MeDALL-CQs consisted of 8 sections, of 
which each was divided into a core section and supple-
mentary questions which remained optional for the co-
horts. The complete MeDALL-CQs are presented in on-
line supplemantary figure 1–3. Please see online supple-
mentary figure 4 for references of the single items of the 
MeDALL-CQs.
 The MeDALL-AQ, 14–18 years, included 66 core-sec-
tion items and 19 optional items for adolescents (online 
suppl. fig.  1). The parent-reported MeDALL-PQ, 14–
18 years, included 50 core-section items and 5 optional 
items (online suppl. fig. 2). The parent-reported MeDALL-
PQ, 4–9 years, included 56 core-section items and 37 op-
tional items (online suppl. fig. 3).
 Discussion 
 The MeDALL-CQ is, to our knowledge, the first at-
tempt to develop a multilingual common core question-
naire for birth cohorts in allergy and asthma. It has been 
constructed using a rigorous stepwise process and it is 
now used in 11 birth cohorts in 9 European countries. It 
can be expanded to other countries in the world with rel-
atively minor adaptation. This MeDALL-CQ is interop-
erable with historical data of the 14 MeDALL cohorts, 
making it possible to compare part of the data across sev-
eral time points ( table 4 ).
 Limitations 
 In some sections of the questionnaire country-specific 
differences were so profound, for example in the section 
on nutrition, that it was decided that harmonization was 
impossible. Also, questions about educational status had 
to be adapted for each country. The other sections were 
judged to be suitable for the harmonization process and 
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the translations and back-translations of questionnaires 
were found to be correctly translated into the 8 other lan-
guages. However, it cannot be excluded that slightly dif-
ferent wording chosen in other languages has led to dif-
ferent interpretations. This might not be the case for 
questions about factual knowledge, such as ‘how many 
cigarettes do you smoke?’, but rather for questions on 
medical conditions such as ‘wheeze’, for which the gen-
eral public understanding might be limited, and could 
lead to different answering behavior among participants. 
Also, asking for eczema – ‘have you (mother or father) 
ever had eczema?’ – highly depends on the patients’ un-
derstanding of the actual wording, which might also dif-
fer depending on the language used.
 Moreover, the order of the harmonized questions 
within the questionnaire differs between the cohorts. As 
the cohorts should have the possibility to include their 
own questions, the harmonized questions are not asked 
in one exclusive part of the questionnaire, but are instead 
integrated in different sections of the cohorts’ own ques-
tionnaires. Not only the order, but also the way in which 
the questionnaires can be filled out varies in terms of us-
ing paper and pencil versus online completion. Further-
more, the age of the adolescents to which the question-
naire is given showed a discrepancy between the cohorts 
(14–18 years). No data will be retrieved for the age group 
11–13 years within the MeDALL project. If the MeDALL-
CQ is used in future studies, different ages of participants 
and the order of questions should be considered as one 
source of variability of the results.
 The questionnaires were developed by the extraction 
of questions from former questionnaires, clinical experi-
ence, experience with specific questions in the cohort 
questionnaires and consensus in the research group, and, 
so far, a validation of the core questionnaires is missing. 
The MeDALL-CQ is an instrument under constant devel-
opment and will be modified according to future experi-
ence and results.
 Strengths and Generalizability 
 The harmonized MeDALL questionnaire, measuring 
a variety of health outcomes and possible determinants of 
allergies in childhood and adolescence, is publicly avail-
able in 9 different languages (Danish, Dutch, English, 
French, German, Greek, Italian, Spanish and Swedish) 
and has been used for the age groups 4–9 and 14–18 years.
 For the 6 older birth cohorts, historical childhood data 
and the MeDALL-CQ will be harmonized to analyze lon-
gitudinal exposure-response relationships from child-
hood up to adolescence within the MeDALL project. The Ta
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separated parental and adolescent questionnaire versions 
allowed detailed use of the knowledge of each participant. 
While the parents were expected to give more reliable 
data on questions referring to conditions throughout the 
adolescent’s life, housing situation and topics such as pa-
rental allergies, the adolescents were thought to be the 
more reliable source for information on current allergy 
symptoms, which can also occur without the knowledge 
of the parent, and on environmental exposures such as 
smoke exposure, which do not take place at home.
 The 6 younger birth cohorts provided data up to 
9 years of age in the current MeDALL follow-up. If the 
MeDALL-CQ is continuously used in the coming years, 
in the long-run these will be the cohorts with prospec-
tively harmonized data, available from early childhood up 
to adolescence. Time-consuming data harmonization 
processes will be unnecessary in the future.
 The construction of the ISAAC questionnaire was a 
major achievement in the field of asthma and allergy as-
sessment, it encouraged networking between European 
cohorts, as in GA 2 LEN, and was the base on which many 
data harmonization projects such as ENRIECO have been 
built. MeDALL is taking this approach one step further 
by including a bigger pool of harmonized variables and 
using existing European birth cohorts as a data source 
with already existing historical data and further follow-
ups planned for the coming years. MeDALL will offer a 
harmonized assessed multicountry sample of over 13,000 
parent-child pairs.
 Conclusion 
 The harmonized follow-up of 11 European birth co-
horts in MeDALL will produce more comparable data 
across different cohorts and countries in Europe. In ad-
dition, all participating cohorts are allowed to include ad-
ditional questions and instruments following their own 
special research interests, so that focused knowledge 
about specific local issues is obtained. The harmonized 
follow-up, however, does not reduce the need to harmo-
nize historical data of the participating cohorts for com-
bined longitudinal analyses.
 Understanding geographical and time patterns of al-
lergic diseases is a challenge. Results from the harmo-
nized MeDALL follow-up will provide more insight into 
true differences or similarities between cohorts and/or 
countries in Europe. This new harmonized assessment 
will offer the possibility to verify results of former com-
bined analyses for which otherwise extensive efforts of 
data harmonization are necessary. Thus, MeDALL can 
become the starting point to stringently plan, conduct 
and support future common asthma and allergy research 
initiatives in Europe.
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